Holen Sie sich die Stockscreener-App
7.18
2.12%
-0.13
Finanzdaten der Day One Biopharmaceuticals Inc-Aktie (DAWN)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
10.23%
33.91
|
30.76 | 29.21 | 93.76 | 8.192 |
Operating Expenses
|
4.10%
68.88
|
71.83 | 94.54 | 64.12 | 123.00 |
| Benefits Costs and Expenses |
-
|
- | - | - | 123.00 |
| Costs And Expenses |
4.10%
68.88
|
71.83 | 94.54 | 64.12 | 123.00 |
| Operating Income/Loss |
14.84%
-34.97
|
-41.07 | -65.33 | 29.64 | -114.81 |
| Nonoperating Income/Loss |
8.26%
4.652
|
5.071 | 6.092 | 6.519 | 111.95 |
| Income/Loss From Continuing Operations Before Tax |
194.20%
33.91
|
-36.00 | 29.21 | 93.76 | -4.407 |
| Income Tax Expense/Benefit |
-
|
- | 6.474 | -0.882 | 1.552 |
| Income/Loss From Continuing Operations After Tax |
194.20%
33.91
|
-36.00 | -6.474 | 0.882 | -4.407 |
|
Net Income/Loss
|
100.00%
-
|
-36.00 | -6.474 | 0.882 | -4.407 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
15.76%
30.32
|
36.00 | 59.24 | -36.16 | 2.855 |
| Basic Average Shares |
0.35%
103.07
|
102.71 | 3.0693 | 96.62 | 87.12 |
| Diluted Average Shares |
0.35%
103.07
|
102.71 | 3.0693 | 96.94 | 87.12 |
| Basic Earnings Per Share |
17.14%
-0.29
|
-0.35 | -0.69 | 0.38 | -0.05 |
| Diluted Earnings Per Share |
17.14%
-0.29
|
-0.35 | -0.69 | 0.38 | -0.05 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
1.17%
0.04%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):